組織検査の世界市場：免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法...市場調査レポートについてご紹介

1 Introduction (Page No. – 10)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 13)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 20)

4 Premium Insights (Page No. – 25)
4.1 Global Tissues Diagnostics Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 28)
5.1 Introduction
5.1.1 By Disease
5.1.2 By End User
5.1.3 By Product
5.1.4 By Technology
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidences of Cancer
5.2.1.2 Rapidly Increasing Aging Population
5.2.1.3 Growing Healthcare Expenditure
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements and Compliance
5.2.2.2 High Degree of Consolidation
5.2.2.3 Budget Constraints
5.2.3 Opportunities
5.2.3.1 High Growth in Emerging Markets
5.2.3.2 Increased Use of Personalized Medicine
5.2.4 Trends
5.2.4.1 Increasing Number of Reagent Rental Agreements

6 Tissue Diagnostics Market, By Product (Page No. – 37)
6.1 Introduction
6.2 Consumables
6.2.1 Antibodies
6.2.2 Kits
6.2.3 Reagents
6.2.4 Probes
6.3 Instruments
6.3.1 Slide-Staining Systems
6.3.2 Scanners
6.3.3 Tissue-Processing Systems
6.3.4 Other Instruments

7 Tissue Diagnostics Market, By Diseases (Page No. – 54)
7.1 Introduction
7.2 Breast Cancer
7.3 Gastric Cancer
7.4 Lymphoma
7.5 Prostate Cancer
7.6 Non-Small Cell Lung Cancer
7.7 Other Diseases

8 Tissue Diagnostics Market, By Technology (Page No. – 67)
8.1 Introduction
8.2 Immunohistochemistry (IHC)
8.3 in Situ Hybridization (ISH)
8.4 Digital Pathology and Workflow Management
8.5 Special Staining

9 Tissue Diagnostics Market, By End User (Page No. – 76)
9.1 Introduction
9.2 Hospitals
9.3 Research Laboratories
9.4 Pharmaceutical Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Tissue Diagnostics Market, By Region (Page No. – 85)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 120)
11.1 Introduction
11.2 Strategic Overview
11.3 Leading Players in the Tissue Diagnostics Market
11.4 Competitive Situation and Trends
11.4.1 New Products Launches and Product Upgrades
11.4.2 Acquisitions
11.4.3 Expansions
11.4.4 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships
11.4.5 Other Developments

12 Company Profiles (Page No. – 129)
12.1 Introduction
12.2 Abbott Laboratories, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Agilent Technologies, Inc.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Bio Sb
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Biogenex Laboratories
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Cell Signaling Technology, Inc.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Danaher Corporation
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.7.4 MnM View
12.8 F. Hoffman-La Roche AG
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments
12.8.4 MnM View
12.9 Sakura Finetek Japan Co., Ltd.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments
12.10 Sigma-Aldrich Corporation
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Recent Development
12.10.4 MnM View
12.11 Thermo Fisher Scientific
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments
12.11.4 MnM View

13 Appendix (Page No. – 156)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports